Abstract: The invention relates to a method of preparing a chlorinated, brominated, radiobrominated, iodinated and/or radioiodinated aromatic or heteroaromatic compound, in which the (hetero)aromatic nucleus optionally comprises one or more additional substituents, by reacting the corresponding halogenated or diazonium-substituted compound in the presence of a water-soluble acid and of copper ions as a catalyst with a likewise water-soluble chloride, bromide radiobromide, iodide or radio-iodide, in which the reaction is carried out in the presence of one or more reduction agents, which are stable in acid medium, in a quantity exceeding the quantity of catalyst. The invention also relates to a composition suitable for diagnostic examination and to a kit for the preparation thereof. The invention further relates to a method and an equipment for the preparation of said composition.

Abstract: A formulation is provided for the treatment of synovial inflammation, the formulation consisting of dysprosium-165 hydroxide macroaggregates or yttrium-90 hydroxide macroaggregates, wherein the formulation is substantially devoid of other co-precipitating agents in particular, ferric hydroxide. A method of treatment of synovial inflammation is also provided in which the method comprises adminstering an intra-articular injection of the above formulation. Preferably the above formulation is in the form of a isotonic apyrogenic injectable solution.

Abstract: A capsule for encapsulating radioactive material for radiation treatment comprising two or more interfitting sleeves, wherein each sleeve comprises a closed bottom portion having a circumferential wall extending therefrom, and an open end located opposite the bottom portion. The sleeves are constructed to fit over one another to thereby establish an effectively sealed capsule structure.

Abstract: A diagnostic aid for the scintigraphic visualization of malignant tumors which contains a radionuclide which is bonded by means of a complex-forming agent to the substance obtained by the enzymatic processing of murein with enzyme consisting essentially of hen's eggwhite lysozyme.

Abstract: There is provided a generator for short-lived radionuclides. The generator comprises a support, an ion-exchange agent and a parent radionuclide in a steady-state equilibrium with a daughter nuclide, which daughter nuclide can be selectively eluted from said column. A suitable parent radionuclide is .sup.191 OS in equilibrium with .sup.191m Ir. There is also provided a specific Os(VI) complex which has certain advantages.

Abstract: Disclosed is an improved autoradiography enhancer composition and method of use. The enhancer composition uses an acid anhydride as a dehydration agent.

Abstract: A drivable radioactive source capsule is provided which comprises a tubular body containing therein a plurality of radioactive sources. The said tubular body has a first end and a second end which is a terminus of the tubular body. A plug has an elongated closure portion with the diameter of the closure portion being substantially equal to the inside diameter of said tubular body. The closure portion is disposed within the tubular body through the second end thereof and is attached to the second end of the tubular body. The plug has a connection portion adjacent the closure portion with the diameter of the connecting portion being substantially equal to the outside diameter of the tubular body. An elongated flexible drive cable is connected to the connection portion of the plug.

Abstract: A process for preparing a tungsten-188/rhenium-188 generator having a tungstate matrix containing W-188 produced by irradiating tungsten-186 in the tungstate compound. High activity, carrier-free rhenium-188 may be obtained by elution. Substrates for further purifying the rhenium-188 eluate are also described.

Abstract: A partitioning radioactive tracer material is prepared by reacting an alkali-metal salt of radioactive iodine with chloroethanol in the presence of activated carbon.

Abstract: A radioactive diagnostic or therapeutic agent, which comprises a metallic element-labeled high molecular compound which comprises one unit of (1) a polyamine compound having at least three amino groups in the side chains per molecule, at least two units of (2) a chelate-forming compound having a carboxyl group, at least one unit of (3) a physiologically active substance and (4) at least two radioactive metallic elements, each unit of the chelate-forming compound (2) and the physiologically active substance (3) being combined to any of the amino groups in the side chains of the polyamine compound (1) and each of the radioactive metallic element (4) being chelate-bonded to the chelate-forming compound (2).

Abstract: A target for the reduction of fission product Mo-99 is prepared from uranium of low U-235 enrichment by coating a structural support member with a preparatory coating of a substantially oxide-free substrate metal. Uranium metal is electrodeposited from a molten halide electrolytic bath onto a substrate metal. The electrodeposition is performed at a predetermined direct current rate or by using pulsed plating techniques which permit relaxation of accumulated uranium ion concentrations within the melt. Layers of as much as to 600 mg/cm.sup.2 of uranium can be prepared to provide a sufficient density to produce acceptable concentrations of fission product Mo-99.

Abstract: Silica gels modified with amino groups or magnesium silicates are suitable carrier materials for technetium-99m generators since they retain copper(II) ions well and thus produce a copper-free eluate.

Abstract: A physiologically acceptable solution of tantalum-178 having an activity of 0.1 to 200 millicuries per milliliter of tantalum-178 solution is provided. The solution is obtained from tungsten-178 bound to a column of an anion exchange resin which forms tantalum-178 in situ by eluting the column with a hydrochloric acid solution containing hydrogen peroxide to form an acidic solution of tantalum-178. The acidic solution of tantalum-178 then is neutralized.

Abstract: A radiography source, preferably a cobalt-60 source constructed of a plurality of radioactive cobalt-60 pellets contained in an open capsule preferably constructed of titanium. The pellets are disposed in the capsule and compacted therein to reduce the source focal size. A plug is disposed in the open capsule and welded therewith. The cobalt and titanium materials are sufficiently different in atomic number to permit good X-ray analysis resolution.

Abstract: A method for preparing radiopharmaceutical complexes that are substantially free of the reaction materials used to produce the radiopharmaceutical complex is disclosed. The method involves admixing in a suitable first solvent in a container a target seeking ligand or salt or metal adduct thereof, a radionuclide label, and a reducing agent for said radionuclide, thereby forming said radiopharmaceutical complex; coating the interior walls of the container with said pharmaceutical complex; discarding the solvent containing by-products and unreacted starting reaction materials; and removing the radiopharmaceutical complex from said walls by dissolving it in a second solvent, thereby obtaining said radiopharmaceutical complex substantially free of by-products and unreacted starting materials.

Abstract: A stabilizer for radioactively labelled organic compounds has the general formula ##STR1## where R is C1 to C4 alkylene which may be OH substituted, m is 0 or 1 (i.e. R may be absent or present), X is carboxyl or sulphonyl e.g. COOH or SO.sub.3 H or a salt thereof and n is 1, 2 or 3. Radiolabelled compounds of biological origin, such as nucleotides and amino acids, may be stabilized either in solution or in the freeze-dried state. For example, L-[.sup.35 S]methionine may be stabilized to prevent formation of a 47 KD band in protein transcription/translation experiments.

Abstract: A radioactive microsphere for radiation therapy of a mammal comprising a biologically compatible glass material containing a beta or gamma emitting radioisotope distributed substantially uniformly throughout the glass. Advantageously, the radioisotope is produced by irradiation of the microsphere.

Abstract: This invention relates to a standard component .sup.99m TC elution generator useful for medical purposes and consisting of prefabricated component parts. The main generator column of the device may be used both as an irradiation container and an elution container, enabling the user to supply activated or nonactivated parts. The main generator column made from by neutrns little activable materials serves first as reactor irradiation ampoule and after having been activated in the reactor by neutrons and after a simple adjustment serves directly as the generator column. It is filled with water insoluable molybdates or polymolybdates (with the molybdenum content in the range 10-40%), easily releasing .sup.99m Tc generated by radioactive decay of the mother .sup.99 Mo formed in it by neutron activation. This column filling serves originally as target material for reactor irradiations and afterwards it is directly used as the generator elution matrix.

Abstract: The subject invention provides an autofluorography kit composition comprising (i) a first aqueous solution of a water soluble fluor having a formula selected from R--CO.sub.2 --X; R--SO.sub.3 --X; and R--NH.sub.3 --Y; where X and Y are any counterion capable of imparting water solubility, and R is a fluor molecule; and (ii) a second aqueous solution of a precipitator capable of precipitating the water soluble fluor in an electrophoresis gel matrix.

Abstract: Beryllium-7 labeled carbon particles made from the proton irradiation of carbon materials, preferably from dry carbon black are disclosed. Such particles are useful as gamma emitting radiotracers.

Abstract: The invention relates to a process for the recovery of molybdenum-99 from an irradiated uranium alloy target.This process comprises the following stages:(a) dissolving the irradiated uranium alloy target in sulphuric acid,(b) separating the iodine and tellurium present in the thus obtained solution,(c) oxidizing the molybdenum-99 present in the Mo (VI) solution, and(d) extracting the thus oxidized molybdenum-99 with a hydroxamic acid of formula: ##STR1## in which R is a radical chosen from the group including straight or branched-chain alkyl radicals, the phenyl radical, phenyl radicals substituted by at least one alkyl radical, arylalkyl radicals and the cyclohexyl radical and R' is a hydrogen atom or an alkyl radical.The hydroxamic acid can be tri-n-butylacetohydroxamic acid and the molybdenum recovered can be used in a technetium generator for medical purposes.

Abstract: A generator system to provide iridium-191m for clinical imaging applications comprises an activated carbon adsorbent loaded with a compound containing the parent nuclide, osmium-191. The generator, which has a shelf-life in excess of two weeks and does not require a scavenger column, can be eluted with physiologically compatible saline.

Abstract: A method, composition of matter, and apparatus for producing substantially pure Ag-109m for use in biomedical imaging techniques. Cd-109, which decays with a half-life of 453 days to Ag-109m is loaded onto an ion exchange column consisting of particulate tin phosphate. After secular equilibrium is reached in about ten minutes, Ag-109m may be selectively eluted from the column by means of a physiologically acceptable aqueous buffered eluent solution of sodium thiosulfate, and either ascorbic acid or dextrose. The breakthrough of toxic Cd-109 is on the order of 1.times.10.sup.-7, which is sufficiently low to permit administration of the Ag-109m-containing eluate, with but a minor pH adjustment, directly to a human patient within a matter of seconds.

Abstract: A method and apparatus for providing radionuclides of bismuth-212 and lead-212. Thorium-228 and carrier solution starting material is input to a radiologically contained portion of an isotopic generator system, and radium-224 is separated from thorium-228 which is retained by a strongly basic anion exchange column. The separated radium-224 is transferred to an accessible, strongly acidic cationic exchange column. The cationic column retains the radium-224, and natural radioactive decay generates bismuth-212 and lead-212. The cationic exchange column can also be separated from the contained portion of the system and utilized without the extraordinary safety measures necessary in the contained portion. Furthermore, the cationic exchange column provides over a relatively long time period the short lived lead-212 and bismuth-212 radionuclides which are useful for a variety of medical therapies.

Abstract: A process for the production of radioiodinated spiperone and certain derivatives thereof, and novel compositions made by the process. The process includes reacting spiperone, thallium trichloride and radioiodine in a sealed reaction vial. The novel compounds are useful for diagnosis of disease states resulting in quantitative changes in dopaminergic receptors.

Abstract: A method for preparing a .sup.195m Au-containing liquid is provided. In the method, .sup.195m Hg is adsorbed on an adsorption agent and then the daughter radioisotope .sup.195m Au is eluted from the adsorption agent with an eluant containing a gold-complexing agent. The adsorption agent comprises a mercury ion-binding material having a substantially stronger adsorption affinity for mercury ions than for gold ions.Also disclosed are a radioisotope generator capable of producing a .sup.195m Au-containing liquid and a process for conducting a radiodiagnostic examination on a warm-blooded animal using a .sup.195m Au-containing liquid.

Abstract: Hydroxylapatite, a compound having the formulaM.sub.10 (PO.sub.4).sub.6 (OH).sub.2,wherein M is calcium, strontium, barium, lead, iron, sodium, potassium, zinc, cadmium, magnesium, aluminum or a rare earth metal, as a support medium for strontium-82 in a strontium-82/rubidium-82 parent-daughter radionuclide generator.

Abstract: Water soluble fluors useful in enhancing images obtained in autoradiography have the general formula:[F].sub.x [B].sub.y [S].sub.zF is a moiety which acts as a fluor, e.g., a dehydro derivative of a compound which is a fluor; preferred examples include 4-(2,5-diphenyloxazolyl), 1-naphthylmethyl, 2-naphthyl, and 4-[5-(2-phenyloxazolyl)]phenyl. S is a surfactant moiety which makes the molecule hydrophilic, e.g., dehydro derivatives of surfactants; preferred examples include polyethylene glycol derivatives, sulfonic acids or salts thereof, aryl sulfonates, amines and quaternary ammonium compounds. B is a binding moiety which chemically binds the fluor moiety F with the surfactant S, and may be a chemical bond, or a disubstituted moiety such as an alkylene, e.g., methylene group. The variables x, y and z are integers which can generally vary from 1 to 10.

Abstract: F(ab').sub.2 or Fab fragments of antibodies to: (a) human chorionic gonadotropin (hCG), hCG alpha subunit, hCG beta subunit, or an hCG-like material; or (b) other tumor specific or tumor associated molecules, to include carcinoembryonic antigen (CEA), alpha fetoprotein (AFP), human melanoma associated antigens, human sarcoma associated antigens or other antigens, are radiolabeled with technetium-99m (Tc-99m). When the F(ab').sub.2 or Fab fragments of antibody to such tumor associated antigens are injected intravenously into a patient, the radiolabeled composition accumulates at tumor sites. The accumulation of the cancer seeking radiopharmaceutical at tumor sites permits detection by external gamma scintigraphy. Thus, the composition is useful in the monitoring, localization and detection of cancer in the body.In an alternative composition, a double antibody approach to tumor localization using radiolabeled F(ab').sub.2 or Fab fragments is utilized.

Abstract: A generator of radionuclides such as technetium-99m comprises a generator column (10) containing the radionuclide, a first reservoir (16) for eluent, a second reservoir (18) to contain a volume of the eluent required for a single elution, and a vessel 40 to contain eluate. First, a pre-set volume of eluent is transferred from the first to the second reservoir; then the eluent is sucked from the second reservoir through the column into the eluate vessel. A hydrophobic filter 32 adjacent the second reservoir (18) permits the use of air to dry the column (10) and to bring the partly filled eluate vessel (40) to atmospheric pressure.

Abstract: A purified peptide isolated from fibrinogen Fragment D.sub.1 and having the amino acid sequence Thr-Arg-Trp-Tyr-Ser-Met-Lys-Lys-Thr-Thr-Met-Lys-Ile-Ile-Pro-Phe-Asn-Arg-Le u-Thr-Ile-Gly-Glu-Gly-Gln-Gln-His-His-Leu-Gly-Gly-Ala-Lys-Gln-Ala-Gly-Asp-V al. The peptide is isloated by degrading Fragment D.sub.1 of fibrinogen with plasmin followed by separation of the resulting peptides on the basis of molecular weight and affinity for bound fibrin monomer. The purified peptide is useful as an anticoagulant and, when suitably labeled with a gamma-emitting radioisotope, as a thrombus imaging agent.

Abstract: There is disclosed an effective direct-acting iodinating reagent for biological specimens which, because it is direct, avoids the necessity of having present at the same time both an oxidizing agent and sodium iodide. The reagent is a conjugate of an iodous ion and a water insoluble support. The manner of conjugation is such that the ion is complexed onto the surface of the support but is still free to react with groups in proteins susceptible to iodination and thus be transferred to the biological specimen being iodinated. Apart from the advantage of being direct-acting, the reagent has those desirable attributes which are associated with water insoluble oxidants.

Abstract: An improved oxidant useful in mediating the iodination of biological specimens containing tyrosyl or synthetically incorporated phenolic residues is disclosed. The oxidant is water insoluble, is easy to handle, and can be prepared with a determinable oxidizing capacity. An illustrated oxidant is a polystyrene bead having covalently attached to its surface N-chlorobenzenesulfonamide groups.

Abstract: An immunological substance detecting reagent is provided which, in the preferred embodiment, employs an immunological homolog specific for the immunological substance to be detected coupled to a water-soluble polymer having a net charge not greater than zero. The water-soluble polymer further has associated a plurality of marker substances such as fluorophore molecules thereby providing a reagent of increased sensitivity for the detection of an antigen-antibody immunological reaction.

Abstract: A radioactive diagnostic agent for renal cortex, adrenal cortex, myocardium, brain stem, spinal nerve, etc., which comprises as an essential component monoiodoacetic acid wherein the iodine atom is radioactive.

Abstract: A method for preparing a .sup.195m Au-containing liquid is provided. In the method, .sup.195m Hg is adsorbed on an adsorption agent and then the daughter radioisotope .sup.195m Au is eluted from the adsorption agent with an eluant containing a gold-complexing agent. The adsorption agent comprises a mercury ion-binding material having a substantially stronger adsorption affinity for mercury ions than for gold ions.Also disclosed are a radioisotope generator capable of producing a .sup.195m Au-containing liquid and a process for conducting a radiodiagnostic examination on a warm-blooded animal using a .sup.195m Au-containing liquid.

Abstract: A composition comprising .sup.82 Sr and an adsorbant selected from the group consisting of tin oxide, hydrated tin oxide, polyantimonic acid, titanium oxide, and ferric oxide.A low .sup.82 Sr breakthrough method of generating .sup.82 Rb from a .sup.82 Sr charged adsorbant comprising eluting wherein said adsorbant is selected from the group consisting of tin oxide, polyantimonic acid, titanium oxide, ferric oxide, and hydrated tin oxide.

Abstract: This invention relates to improved energy-emitting latex-particulates for use in a non-destructive method of biological assay, wherein the biological material under assay links the distinct and different particulates in such a manner that their proximity results in a detectable signal which is indicative of the amount of such biological material present in the fluid.More particularly, this invention relates to improved energy-emitting latex-particulates which have improved stability, a greatly extended shelf-life, particularly in the fluid suspension state, and whose use in the quantitative assay of immunological material results in a reduced background signal and improved sensitivity and stability.